Civil service commission

ESAs consult on technical standards for joint examination teams under DORA

Retrieved on: 
Jeudi, avril 18, 2024

ESAs consult on technical standards for joint examination teams under DORA

Key Points: 
  • ESAs consult on technical standards for joint examination teams under DORA
    The European Supervisory Authorities (EBA, EIOPA and ESMA – the ESAs) launched today a public consultation on the draft Regulatory Technical Standards (RTS) on the conduct of oversight activities in relation to the joint examination teams under the Digital Operational Resilience Act (DORA).
  • The proposed technical standards take into account the high technical complexity of the oversight activities and the scarce availability of the expertise needed to perform them.
  • Legal basis, background and next steps
    These draft technical standards have been developed in accordance with Article 41(1) point (c) of DORA (Regulation (EU) 2022/2554).
  • The ESAs expect to submit these draft technical standards to the European Commission by 17 July 2024.

20 Talks - Amandeep Singh Gill, UN Secretary General's Envoy on Technology

Retrieved on: 
Jeudi, avril 18, 2024

20 Talks - Amandeep Singh Gill, UN Secretary General's Envoy on Technology

Key Points: 
  • 20 Talks - Amandeep Singh Gill, UN Secretary General's Envoy on Technology
    In this episode, our guest is Amandeep Singh Gill, UN Secretary General's Envoy on Technology.
  • In this episode, our guest is Amandeep Singh Gill, UN Secretary General's Envoy on Technology.
  • The EDPS presents its Annual Report 2023, summarising its key achievements in an evolving digital and regulatory landscape.
  • Read Press Release
    Read the decision
    On 20 June 2024, we invite you to the European Data Protection Summit: “Rethinking Data in a Democratic Society”.

EU-US Hold Fourth Joint Technology Competition Policy Dialogue

Retrieved on: 
Vendredi, avril 12, 2024

Today, Federal Trade Commission Chair Lina Khan, the Justice Department’s Antitrust Division (DOJ) Assistant Attorney General Jonathan Kanter, and European Commission Executive Vice-President Margrethe Vestager met in Washington for the fourth meeting of the EU-US Joint Technology Competition Policy Dialogue (TCPD) to continue work on cooperation in ensuring and promoting fair competition in the digital economy.

Key Points: 
  • Today, Federal Trade Commission Chair Lina Khan, the Justice Department’s Antitrust Division (DOJ) Assistant Attorney General Jonathan Kanter, and European Commission Executive Vice-President Margrethe Vestager met in Washington for the fourth meeting of the EU-US Joint Technology Competition Policy Dialogue (TCPD) to continue work on cooperation in ensuring and promoting fair competition in the digital economy.
  • The fast-moving technology sector raises global challenges such as regarding artificial intelligence and cloud computing more broadly.
  • The three authorities have agreed on the importance of continuing their close collaboration in the framework of the TCPD to ensure fair competition in the technology sector.
  • The Federal Trade Commission works with counterpart agencies to promote sound antitrust, consumer protection, and data privacy enforcement and policy.

EU-US Hold Fourth Joint Technology Competition Policy Dialogue

Retrieved on: 
Vendredi, avril 12, 2024

Today, Federal Trade Commission Chair Lina Khan, the Justice Department’s Antitrust Division (DOJ) Assistant Attorney General Jonathan Kanter, and European Commission Executive Vice-President Margrethe Vestager met in Washington for the fourth meeting of the EU-US Joint Technology Competition Policy Dialogue (TCPD) to continue work on cooperation in ensuring and promoting fair competition in the digital economy.

Key Points: 
  • Today, Federal Trade Commission Chair Lina Khan, the Justice Department’s Antitrust Division (DOJ) Assistant Attorney General Jonathan Kanter, and European Commission Executive Vice-President Margrethe Vestager met in Washington for the fourth meeting of the EU-US Joint Technology Competition Policy Dialogue (TCPD) to continue work on cooperation in ensuring and promoting fair competition in the digital economy.
  • The fast-moving technology sector raises global challenges such as regarding artificial intelligence and cloud computing more broadly.
  • The three authorities have agreed on the importance of continuing their close collaboration in the framework of the TCPD to ensure fair competition in the technology sector.
  • The Federal Trade Commission works with counterpart agencies to promote sound antitrust, consumer protection, and data privacy enforcement and policy.

Curium Announces First Commercial Dose in the Netherlands of PYLCLARI® – an Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer

Retrieved on: 
Mardi, avril 9, 2024

PARIS, April 09, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced that today in the Netherlands the first commercial dose of PYLCLARI® has been sold.

Key Points: 
  • PARIS, April 09, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced that today in the Netherlands the first commercial dose of PYLCLARI® has been sold.
  • In the U.S., Lantheus received approval for PYLARIFY® (Piflufolastat F 18 Injection) from the Food and Drug Administration (FDA) in May 2021.
  • It is the #1 utilized PSMA PET agent in the U.S. market.
  • The European rights were licensed by Curium from Progenics, a Lantheus company, in 2018.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in iRobot Corporation of Class Action Lawsuit and Upcoming Deadlines – IRBT

Retrieved on: 
Lundi, avril 8, 2024

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against iRobot Corporation (“iRobot” or the “Company”) (NASDAQ: IRBT) and certain officers.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against iRobot Corporation (“iRobot” or the “Company”) (NASDAQ: IRBT) and certain officers.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • iRobot designs, builds, and sells robots and home innovation products in the U.S., Europe, the Middle East, Africa, Japan, and internationally.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iRobot Corporation (IRBT)

Retrieved on: 
Jeudi, avril 4, 2024

Then, on January 10, 2024, it was reported that Amazon did not offer concessions to the EC regarding concerns about the Merger.

Key Points: 
  • Then, on January 10, 2024, it was reported that Amazon did not offer concessions to the EC regarding concerns about the Merger.
  • On this news, iRobot’s stock price fell $7.33, or 19.8%, to close at $29.75 per share on January 10, 2024.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights

Retrieved on: 
Lundi, avril 1, 2024

BOSTON and LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, has reported financial results for the full year 2023 as well as recent company highlights.

Key Points: 
  • BOSTON and LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, has reported financial results for the full year 2023 as well as recent company highlights.
  • The combined entity will operate as Akari Therapeutics, Plc, which is expected to continue to be listed and trade on the Nasdaq Capital Market as AKTX.
  • Akari is continuing to recruit patients into the Part A portion of the Phase 3 clinical trial that has treated 10 patients to date.
  • During 2023, Akari also advanced the long-acting version of nomacopan (PASylated nomacopan) into the final stages of pre-clinical development as a treatment for geographic atrophy (GA).

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in iRobot Corporation of Class Action Lawsuit and Upcoming Deadlines – IRBT

Retrieved on: 
Dimanche, mars 31, 2024

NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against iRobot Corporation (“iRobot” or the “Company”) (NASDAQ: IRBT) and certain officers.

Key Points: 
  • NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against iRobot Corporation (“iRobot” or the “Company”) (NASDAQ: IRBT) and certain officers.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • iRobot designs, builds, and sells robots and home innovation products in the U.S., Europe, the Middle East, Africa, Japan, and internationally.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iRobot Corporation (IRBT)

Retrieved on: 
Vendredi, mars 29, 2024

Then, on January 10, 2024, it was reported that Amazon did not offer concessions to the EC regarding concerns about the Merger.

Key Points: 
  • Then, on January 10, 2024, it was reported that Amazon did not offer concessions to the EC regarding concerns about the Merger.
  • On this news, iRobot’s stock price fell $7.33, or 19.8%, to close at $29.75 per share on January 10, 2024.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles